Pain was almost ubiquitous among patients with multiple subtypes of multiple sclerosis, finds a study. Pain was almost omnipresent in measured subtypes of multiple sclerosis (MS), where over one-third ...
People with MS who carry the APOE4 gene variant show greater signs of nerve damage and cognitive decline than those who don't ...
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral inflammation and persistent immune activation within the central nervous system, ...
The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...
A cross-sectional analysis evaluated a myriad of socioeconomic and demographic factors that drive stigma experienced by patients with multiple sclerosis (MS). A study recently published in Multiple ...
People with late-onset MS, who experience their first symptoms after age 50, tend to have faster disability progression, ...
New research from Oregon Health & Science University suggests that people with multiple sclerosis, or MS, could benefit from a low-fat diet to improve the fatigue that’s a debilitating, and ...
This study demonstrated progressive CP enlargement over time in individuals with RRMS, averaging 1.4% a year with significant variation per participant. CP enlargement correlated with the expansion of ...
For women with multiple sclerosis who report cognitive dysfunction — one of the most common and disabling symptoms of the disease — sleep disorders such as insomnia and sleep apnea may contribute to ...
If Derek Stefureac ever doubts that his improbable accomplishments of the past several years really happened, a few memory-jogging objects around his home can offer tangible proof. There’s the running ...
When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results